Okusaka, Takuji
Saiura, Akio
Shimada, Kazuaki
Ikeda, Masafumi
Ioka, Tatsuya
Kimura, Tetsuya
Hosokawa, Jun
Takita, Atsushi
Oba, Mari S.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
https://doi.org/10.1007/s10120-023-01378-1
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
https://doi.org/10.1007/s00535-023-02033-3
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 23 March 2023
Accepted: 7 August 2023
First Online: 7 September 2023
Declarations
:
: Takuji Okusaka received research grants from AstraZeneca K.K., Syneos Health Clinical K.K., and MSD K.K. Akio Saiura and Kazuaki Shimada have no conflicts of interest to disclose. Masafumi Ikeda received honoraria from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Incyte Biosciences Japan G.K., Novartis Pharma K.K., and Takeda Pharmaceutical Co., Ltd.; research grants from AstraZeneca K.K., Bayer Yakuhin, Ltd., Bristol-Myers Squibb K.K., Chiome Bioscience Inc., Chugai Pharmaceutical Co., Ltd., Delta-Fly Pharma, Inc., Eisai Co., Ltd., Eli Lilly Japan K.K., J Pharma Co., Ltd., Merck BioPharma Co., Ltd., Merus. N.V., MSD K.K., Nihon Servier Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Syneos Health Clinical K.K., and Invitae Japan K.K. Tatsuya Ioka received honoraria from Taiho Pharmaceutical Co., Ltd., and AstraZeneca K.K. Tetsuya Kimura, Jun Hosokawa, and Atsushi Takita are employees of Daiichi Sankyo Co., Ltd. Mari S Oba has no conflicts of interest to disclose.